Dieudonné Loumouamou

Learn More
Congo-Brazzaville adopted artemisinin-based combination therapy (ACT) in 2006. Artesunate-amodiaquine (AS + AQ) and artemether-lumefantrine are the first-line and second-line anti-malarial drugs to treat uncomplicated Plasmodium falciparum malaria, respectively. The baseline efficacy of AS + AQ was evaluated from February to August 2005 in patients living(More)
During the surveys on antimalarial drug efficacy carried out from 2003 to 2006, we systematically checked the presence of Plasmodium falciparum in patients consulting in two health centres located in the south of Brazzaville. The first centre is situated in the urban zone; the second, in the semi rural area. The objective of this survey was to determine the(More)
The Republic of the Congo adopted artemisinin-based combination therapies (ACTs) in 2006: artesunate-amodiaquine and artemether-lumefantrine as the first-line and second-line drugs, respectively. The baseline efficacy of artemether-lumefantrine was evaluated between March and July 2006 in Brazzaville, the capital city of Congo. Seventy-seven children aged(More)
  • 1